Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Acta Pharmacol Sin ; 45(8): 1644-1659, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38589686

RESUMEN

Cardiopulmonary progenitor cells (CPPs) constitute a minor subpopulation of cells that are commonly associated with heart and lung morphogenesis during embryonic development but completely subside after birth. This fact offers the possibility for the treatment of pulmonary heart disease (PHD), in which the lung and heart are both damaged. A reliable source of CPPs is urgently needed. In this study, we reprogrammed human cardiac fibroblasts (HCFs) into CPP-like cells (or induced CPPs, iCPPs) and evaluated the therapeutic potential of iCPP-derived exosomes for acute lung injury (ALI). iCPPs were created in passage 3 primary HCFs by overexpressing GLI1, WNT2, ISL1 and TBX5 (GWIT). Exosomes were isolated from the culture medium of passage 6-8 GWIT-iCPPs. A mouse ALI model was established by intratracheal instillation of LPS. Four hours after LPS instillation, ALI mice were treated with GWIT-iCPP-derived exosomes (5 × 109, 5 × 1010 particles/mL) via intratracheal instillation. We showed that GWIT-iCPPs could differentiate into cell lineages, such as cardiomyocyte-like cells, endothelial cells, smooth muscle cells and alveolar epithelial cells, in vitro. Transcription analysis revealed that GWIT-iCPPs have potential for heart and lung development. Intratracheal instillation of iCPP-derived exosomes dose-dependently alleviated LPS-induced ALI in mice by attenuating lung inflammation, promoting endothelial function and restoring capillary endothelial cells and the epithelial cells barrier. This study provides a potential new method for the prevention and treatment of cardiopulmonary injury, especially lung injury, and provides a new cell model for drug screening.


Asunto(s)
Lesión Pulmonar Aguda , Exosomas , Células Madre , Animales , Exosomas/metabolismo , Exosomas/trasplante , Lesión Pulmonar Aguda/terapia , Humanos , Ratones , Células Madre/citología , Células Madre/metabolismo , Fibroblastos/metabolismo , Masculino , Ratones Endogámicos C57BL , Diferenciación Celular , Células Cultivadas , Lipopolisacáridos/farmacología , Pulmón/metabolismo , Pulmón/patología , Modelos Animales de Enfermedad
2.
Am J Physiol Lung Cell Mol Physiol ; 324(2): L89-L101, 2023 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-36472329

RESUMEN

Clinical observation indicates that exercise capacity, an important determinant of survival in patients with congenital heart disease (CHD), is most decreased in children with reduced pulmonary blood flow (RPF). However, the underlying mechanism remains unclear. Here, we obtained human RPF lung samples from children with tetralogy of Fallot as well as piglet and rat RPF lung samples from animals with pulmonary artery banding surgery. We observed impaired alveolarization and vascularization, the main characteristics of pulmonary dysplasia, in the lungs of RPF infants, piglets, and rats. RPF caused smaller lungs, cyanosis, and body weight loss in neonatal rats and reduced the number of alveolar type 2 cells. RNA sequencing demonstrated that RPF induced the downregulation of metabolism and migration, a key biological process of late alveolar development, and the upregulation of immune response, which was confirmed by flow cytometry and cytokine detection. In addition, the immunosuppressant cyclosporine A rescued pulmonary dysplasia and increased the expression of the Wnt signaling pathway, which is the driver of postnatal lung development. We concluded that RPF results in pulmonary dysplasia, which may account for the reduced exercise capacity of patients with CHD with RPF. The underlying mechanism is associated with immune response activation, and immunosuppressants have a therapeutic effect in CHD-associated pulmonary dysplasia.


Asunto(s)
Cardiopatías Congénitas , Alveolos Pulmonares , Lactante , Niño , Animales , Humanos , Ratas , Porcinos , Alveolos Pulmonares/metabolismo , Pulmón/metabolismo , Cardiopatías Congénitas/complicaciones , Cardiopatías Congénitas/metabolismo , Cardiopatías Congénitas/patología , Circulación Pulmonar , Hiperplasia/metabolismo , Hiperplasia/patología , Animales Recién Nacidos
3.
J Thromb Thrombolysis ; 55(2): 399-405, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36637776

RESUMEN

Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and organ ischemia associated with disseminated microvascular platelet-rich thrombus. Before the introduction of plasma therapy, acute TTP was almost universally fatal, which improved survival from < 10 to 80-90%. However, patients who survived an acute attack were at high risk for recurrence and long-term morbidity. It was reported that daratumumab can eradicate persistent ADAMTS13-inhibiting autoantibodies and restore ADAMTS13 activity in two patients with relapsed immune-mediated TTP without associated adverse drug reactions. Here we report a case series of patients with initial diagnosed acquired TTP treated with combination regimens containing daratumumab. All the patients achieved clinical response after the initial treatment. Three patients achieved clinical remission, one patient relapsed and one patient suffered an exacerbation during follow-up. The two patients were retreated with glucocorticoids, plasma exchange combined with daratumumab, and clinical remission was achieved again. Combination of daratumumab in the treatment of initial diagnosed acquired thrombotic thrombocytopenic purpura can rapidly restore ADAMST13 activity and turn negative for ADAMST13 inhibitors, resulting in long-term remission in patients.


Asunto(s)
Púrpura Trombocitopénica Trombótica , Humanos , Púrpura Trombocitopénica Trombótica/diagnóstico , Púrpura Trombocitopénica Trombótica/tratamiento farmacológico , Anticuerpos Monoclonales/uso terapéutico , Intercambio Plasmático/métodos , Proteína ADAMTS13
4.
Pharmazie ; 73(4): 207-212, 2018 04 02.
Artículo en Inglés | MEDLINE | ID: mdl-29609687

RESUMEN

Safranal, a main component of Crocus sativus, is suggested to have neuroprotective effects. The aim of this study was to investigate the effect of safranal and nanostructured lipid vehicle (NLV) carried safranal in acute and chronic experimental mice models of epilepsy. In PILO acute seizure model, safranal dose-dependently extended latency to generalized seizure, decreased the highest seizure stages and the number of generalized seizures. Moreover, NLV carried safranal further enhanced the anti-seizure effect, which is comparable to the action of sodium valproate. Meanwhile, NLV carried safranal reduced and delayed the electroencephalogram spectra power after pilocarpine injection. In histological aspect, safranal dose-dependently reduced the loss of neurons induced by seizure and NLV system further improved this protection at the same dose. In MES acute model, safranal markedly increased the electroconvulsive threshold, where NLV further improved its effect. In PTZ chronic seizure model, NLV carried safranal significantly delayed the kindling rate of progress and the time it took to reach generalized seizures as compared to NLV control group. In conclusion, this study indicates that safranal inhibits generalized seizure in acute and chronic epilepsy models in mice and NLV can enhance this effect. So, NLV carried safranal may have potential value in treatment of generalized epilepsy.


Asunto(s)
Anticonvulsivantes/administración & dosificación , Anticonvulsivantes/uso terapéutico , Ciclohexenos/administración & dosificación , Ciclohexenos/uso terapéutico , Epilepsia Generalizada/tratamiento farmacológico , Terpenos/administración & dosificación , Terpenos/uso terapéutico , Animales , Convulsivantes , Relación Dosis-Respuesta a Droga , Composición de Medicamentos , Electroencefalografía , Electrochoque , Epilepsia Generalizada/inducido químicamente , Excitación Neurológica/efectos de los fármacos , Lípidos/química , Masculino , Ratones , Tamaño de la Partícula , Vehículos Farmacéuticos , Pilocarpina
5.
Cell Prolif ; 57(5): e13593, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38185757

RESUMEN

Ischemic heart disease, especially myocardial infarction (MI), is one of the leading causes of death worldwide, and desperately needs effective treatments, such as cell therapy. Cardiopulmonary progenitors (CPPs) are stem cells for both heart and lung, but their repairing role in damaged heart is still unknown. Here, we obtained CPPs from E9.5 mouse embryos, maintained their stemness while expanding, and identified their characteristics by scRNA-seq, flow cytometry, quantitative reverse transcription-polymerase chain reaction, and differentiation assays. Moreover, we employed mouse MI model to investigate whether CPPs could repair the injured heart. Our data identified that CPPs exhibit hybrid fibroblastic, endothelial, and mesenchymal state, and they could differentiate into cell lineages within the cardiopulmonary system. Moreover, intramyocardial injection of CPPs improves cardiac function through CPPs exosomes (CPPs-Exo) by promotion of cardiomyocytic proliferation and vascularization. To uncover the underlying mechanism, we used miRNA-seq, bulk RNA-seq, and bioinformatic approaches, and found the highly expressed miR-27b-3p in CPPs-Exo and its target gene Sik1, which can influence the transcriptional activity of CREB1. Therefore, we postulate that CPPs facilitate cardiac repair partially through the SIK1-CREB1 axis via exosomal miR-27b-3p. Our study offers a novel insight into the role of CPPs-Exo in heart repair and highlights the potential of CPPs-Exo as a promising therapeutic strategy for MI.


Asunto(s)
Proteína de Unión a Elemento de Respuesta al AMP Cíclico , Exosomas , MicroARNs , Animales , MicroARNs/genética , MicroARNs/metabolismo , Exosomas/metabolismo , Ratones , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/genética , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Serina-Treonina Quinasas/genética , Infarto del Miocardio/metabolismo , Infarto del Miocardio/genética , Infarto del Miocardio/terapia , Células Madre/metabolismo , Células Madre/citología , Proliferación Celular , Diferenciación Celular , Pulmón/metabolismo , Ratones Endogámicos C57BL , Miocardio/metabolismo , Miocardio/citología
6.
Psych J ; 5(2): 101-16, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27144924

RESUMEN

Recent studies have characterized self-control as a vital psychological variable that helps explain various problems. Tangney's Self-Control Scale (SCS) is a self-report measurement to assess individual differences in traits of self-control. It has gained popularity in social and psychological science research. In China, there are a few Chinese-version scales measuring general self-control, which can be applied to college students. The purposes of the present study were to evaluate: (a) the psychometric properties of the Chinese version of Tangney's SCS using confirmatory factor analysis, and (b) whether higher scores on the scale correlated with positive outcomes in China. The final sample in this study consisted of 371 Chinese college students aged 17-23 years. The Full SCS and Brief SCS were both found to have a reasonable fitness, which also had satisfactory internal consistencies and a high correlation. Higher scores on the SCS correlated with higher self-esteem, extraversion, better harmony in interpersonal relationships and an appropriate anger expression, less impulsiveness, and state and trait anger. The test-retest reliability was confirmed in two additional samples. Tangney's SCS could be used in China.


Asunto(s)
Pruebas Psicológicas , Autocontrol , Estudiantes/psicología , Adolescente , Adulto , China , Femenino , Humanos , Individualidad , Relaciones Interpersonales , Masculino , Personalidad , Determinación de la Personalidad , Psicometría , Reproducibilidad de los Resultados , Autoinforme , Universidades , Adulto Joven
7.
J Dermatol ; 42(5): 485-95, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25752881

RESUMEN

Excessive scars affect a patient's quality of life, both physically and psychologically, by causing pruritus, pain and contractures. Because there is a poor understanding of the complex mechanisms underlying the processes of hypertrophic scar formation, most therapeutic approaches remain clinically unsatisfactory. In this study, we found that miR-138 was downregulated and peroxisome proliferator-activated receptor (PPARß) was inversely upregulated in hypertrophic scar tissues compared to in paired normal skin tissues. Using a dual-luciferase assay, we validated that miR138 directly targets PPARß and regulates its expression at the transcriptional and translational levels. In gain-and-loss experiments, we found that miR-138/PPARß signaling regulated human hypertrophic scar fibroblast proliferation and movement, and affected scarring-related protein expression, which suggests that miR-138/PPARß signaling is important for hypertrophic scarring. Thus, our study provides evidence to help determine whether miR-138/PPARß signaling may be a potential target for hypertrophic scarring management.


Asunto(s)
Cicatriz Hipertrófica/genética , Cicatriz Hipertrófica/metabolismo , MicroARNs/metabolismo , PPAR-beta/metabolismo , Adolescente , Adulto , Movimiento Celular , Proliferación Celular , Células Cultivadas , Niño , Preescolar , Cicatriz Hipertrófica/patología , Femenino , Fibroblastos/metabolismo , Humanos , Masculino , MicroARNs/genética , PPAR-beta/genética , Transducción de Señal , Transcripción Genética , Adulto Joven
8.
PLoS One ; 7(12): e51849, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23284788

RESUMEN

We previously demonstrated that endogenous hNUDC and Mpl co-localized in the perinuclear and cytoplasmic regions of megakaryocyte cells by indirect immunofluorescence. We further reported that hNUDC accumulated in the Golgi when NIH 3T3 cells were transfected with an hNUDC expression vector alone. However, co-transfection with hNUDC and Mpl expression vectors caused both proteins to co-localize predominantly in the cytosol. These observations led us to hypothesize that a complex containing hNUDC and Mpl may alter hNUDC subcellular location and induce its secretion. In the present study, we test this hypothesis by employing bimolecular fluorescence complementation (BiFC) to detect and visualize the complex formation of hNUDC/Mpl in living cells. We further examined in detail the subcellular locations of the hNUDC/Mpl complex by co-transfection of BiFC chimeras with known subcellular markers. The distribution of hNUDC/Mpl in the endoplasmic reticulum (ER), Golgi and cell surface was determined. Furthermore, the N-terminal 159 amino acids of hNUDC, but not C-terminal half, bound to Mpl in vivo and exhibited a similar localization pattern to that of full-length hNUDC in Cos-1 cells. Adenovirus-mediated overexpression of hNUDC or its N-terminal 159 residues in a human megakaryocyte cell line (Dami) resulted in increased levels of hNUDC or hNUDC(1-159) secretion. In contrast, depletion of Mpl by transfecting Dami cells with adenovirus bearing Mpl-targeting siRNA significantly blocked hNUDC secretion. Thus, we provide the first evidence that the N-terminal region of hNUDC contains all of the necessary information to complex with Mpl and traffic through the secretory pathway.


Asunto(s)
Proteínas de Ciclo Celular/metabolismo , Membrana Celular/metabolismo , Retículo Endoplásmico/metabolismo , Aparato de Golgi/metabolismo , Proteínas Nucleares/metabolismo , Receptores de Trombopoyetina/metabolismo , Adenoviridae/genética , Animales , Western Blotting , Células COS/metabolismo , Células COS/ultraestructura , Proteínas de Ciclo Celular/genética , Chlorocebus aethiops , Medios de Cultivo Condicionados/farmacología , Citometría de Flujo , Transferencia Resonante de Energía de Fluorescencia , Humanos , Microscopía Confocal , Proteínas Nucleares/genética , ARN Interferente Pequeño/genética , Receptores de Trombopoyetina/antagonistas & inhibidores , Receptores de Trombopoyetina/genética , Fracciones Subcelulares
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA